[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100653596":3},{"organization":4,"outcomesModule":7,"designInfo":17,"detailedDescription":24,"studyPopulation":16,"armGroups":25,"interventions":36,"overallOfficials":40,"centralContacts":47,"locations":56,"responsibleParty":72,"collaborators":74,"id":82,"slug":83,"hasResults":84,"nctId":85,"briefTitle":86,"officialTitle":86,"acronym":16,"eligibilityCriteria":87,"healthyVolunteers":88,"sex":89,"minAge":90,"maxAge":16,"enrollmentInfo":91,"targetDuration":16,"studyType":94,"phases":95,"briefSummary":97,"conditions":98,"keywords":101,"overallStatus":105,"whyStopped":16,"lastUpdateSubmitDate":106,"lastUpdatePostDateStruct":107,"startDateStruct":110,"completionDateStruct":112,"leadSponsor":114,"locationsCount":115},{"fullName":5,"class":6},"University of California, San Francisco","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":16},[9],{"measure":10,"description":11,"timeFrame":12},"Biomedical HIV prevention coverage","Percentage of follow-up time that a participant uses a biomedical HIV prevention product.","48 weeks",[14],{"measure":10,"description":11,"timeFrame":15},"96 weeks",null,{"allocation":18,"interventionModel":19,"interventionModelDescription":20,"primaryPurpose":21,"observationalModel":16,"timePerspective":16,"maskingInfo":22},"RANDOMIZED","PARALLEL","Hybrid Type 1 cluster randomized trial to test the effectiveness and implementation outcomes of a Peer-led Dynamic Choice HIV Prevention intervention for women.","PREVENTION",{"masking":23,"maskingDescription":16,"whoMasked":16},"NONE","This study will test a Peer-led Dynamic Choice HIV Prevention intervention tailored to women at elevated risk of HIV exposure in Western and South-Central Uganda. The investigators will conduct a cluster randomized trial to test the effectiveness and implementation outcomes of a Peer-led Dynamic Choice HIV Prevention intervention for women.",[26,32],{"label":27,"type":28,"description":29,"interventionNames":30},"Peer-led Dynamic Choice HIV Prevention (DCP) intervention","EXPERIMENTAL","Participants in the experimental arm will receive the Peer-led Dynamic Choice HIV Prevention intervention.",[31],"Other: Peer-led Dynamic Choice HIV Prevention (DCP) intervention",{"label":33,"type":34,"description":35,"interventionNames":16},"Standard of Care","NO_INTERVENTION","Participants in the standard of care arm will receive brief education on HIV prevention and will be referred to the nearby health facility for HIV prevention services per national guidelines.",[37],{"type":6,"name":27,"description":38,"armGroupLabels":39,"otherNames":16},"The intervention consists of peer mentor training on patient-centered choice counseling and Peer-led DCP services, and will be delivered by the peer mentor with remote clinician support: 1) HIV prevention product choice, with the option to switch over time, 2) HIV testing, 3) Low-barrier PEP, 4) STI integration, 5) Travel kit, and 6) Phone\u002FSMS contact and peer support.",[27],[41,44],{"name":42,"affiliation":5,"role":43},"Catherine Koss, MD","PRINCIPAL_INVESTIGATOR",{"name":45,"affiliation":46,"role":43},"Jane Kabami, PhD, MPH","Infectious Diseases Research Collaboration",[48,52],{"name":42,"role":49,"phone":50,"phoneExt":16,"email":51},"CONTACT","415-476-4082","catherine.koss@ucsf.edu",{"name":53,"role":49,"phone":54,"phoneExt":16,"email":55},"Lisa Georgetti Gomez, MSPH","415-539-5688","lisa.georgetti@ucsf.edu",[57],{"facility":46,"status":16,"city":58,"state":16,"zip":16,"country":59,"countryCode":60,"cosmosGeoPoint":61,"geoPoint":66,"contacts":67},"Kampala","Uganda","UG",{"type":62,"coordinates":63},"Point",[64,65],32.58219,0.31628,{"lat":65,"lon":64},[68],{"name":69,"role":49,"phone":70,"phoneExt":16,"email":71},"Jane Kabami, MPH, PhDc","+256 312 281-479","jkabami@idrc-uganda.org",{"type":73,"investigatorFullName":16,"investigatorTitle":16,"investigatorAffiliation":16,"oldNameTitle":16,"oldOrganization":16},"SPONSOR",[75,78,80],{"name":76,"class":77},"National Institute of Mental Health (NIMH)","NIH",{"name":79,"class":6},"Infectious Diseases Research Collaboration, Uganda",{"name":81,"class":6},"University of California, Berkeley","100653596","peer-led-dynamic-choice-hiv-prevention-for-women-the-peer-led-dcp-randomized-trial-100653596",false,"NCT07787988","Peer-led Dynamic Choice HIV Prevention for Women: The Peer-led DCP Randomized Trial","Inclusion Criteria:\n\n1. Age \\>=15 years (with parent\u002Fguardian consent required for age 15 to \\\u003C18 years)\n2. Female sex at birth;\n3. HIV negative by country-standard testing algorithm;\n4. Elevated risk of HIV exposure, defined as at least 1 of the following: a) eligible for PrEP\u002FPEP based on Uganda Ministry of Health Guidelines or b) work in bar or guesthouse\n\nExclusion Criteria:\n\n1. Contraindication to recommended PrEP\u002FPEP regimen per Ministry of Health guidelines\n2. Participation in another HIV prevention study\n3. Aged 15 to \\\u003C18 years with no parent or guardian to provide consent",true,"FEMALE","15 Years",{"count":92,"type":93},560,"ESTIMATED","INTERVENTIONAL",[96],"NA","This Hybrid Type 1 cluster randomized trial will test the Peer-led Dynamic Choice HIV Prevention (DCP) intervention compared to standard of care.",[99,100],"HIV\u002FAIDS","HIV\u002FAIDS Prevention",[102,103,59,104],"Biomedical HIV Prevention","Peer Mentor Intervention","Dynamic Choice HIV Prevention","NOT_YET_RECRUITING","2026-08-31",{"date":108,"type":109},"2026-09-02","ACTUAL",{"date":111,"type":93},"2026-09-15",{"date":113,"type":93},"2029-12-31",{"name":5,"class":6},1]